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Optimising the Performance of Intermittent Pneumatic Compression
Devices
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Objectives: this study was designed to determine whether an intermittent pneumatic compression device (IPC) with an
increased maximal inflation pressure, a decreased time to maximal pressure and a longer duration of compression would
improve venous return compared to a standard IPC device.
Methods: thirty limbs in 15 volunteers without evidence of venous disease were studied using duplex scanning at rest
and during the application of two different IPC devices with different compression parameters. The first device IPC-1
(SCD 5325, Kendall) has a six-chambered cuff applying 45 mmHg after 12 s, sequentially from ankle to thigh followed
by 60 s of non-compression. The second device IPC-2 (Vena-Assist, ACI Medical) has a foot, ankle and calf cuff, applies
a pressure of 80 mmHg, has a pressure rise time of 0.3 s, maintains inflation for 5.5 s, and has a cycling time of 1 min.
Peak venous velocity and acceleration time were measured at rest and during the IPC application. Measurements were
obtained in supine position from the common femoral vein 1 cm above the saphenofemoral junction to include the entire
venous outflow from the limb.
Results: peak venous velocity at rest was significantly higher in the right limb than in the left limb (26±7.2 vs.
22±5.7 cm/s, p<0.01). Peak venous velocity was significantly increased by both IPC devices (p<0.0001). IPC-2 achieved
significantly higher peak venous velocity than IPC-1 (55.1±17.8 vs. 37.4±6.9 cm/s, p<0.0001). Acceleration time was
also found to be significantly shorter (370±93.4 vs. 560±83.5 ms, p<0.0001) in IPC-2 than in IPC-1, respectively.
Conclusions: we have demonstrated that progressive inflation at the foot, ankle and calf, increasing maximal inflation
pressure and decreasing time to maximal pressure result in increased venous return. These changes may improve the
efficacy of IPC devices in the prevention of deep-venous thrombosis (DVT) formation.
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Introduction pressure,3 and decreased inflation duration4 during
pneumatic compression of the foot results in greater
Deep-venous thrombosis (DVT) remains one of the increases in peak velocity. No studies have compared
the haemodynamic profiles of thigh-length IPC de-most feared postoperative complications, contributing
significantly to morbidity and mortality.1,2 The use of vices, which have become the standard of prophylactic
therapy following most surgical procedures, with foot,external, intermittent pneumatic compression (IPC)
has become the standard of care in the non-phar- ankle and calf rapid inflation devices. An early study
demonstrated that increasing mean inflation pressuresmacological prophylaxis against DVT formation. De-
spite the reduction in DVT formation with the use of in a thigh-length IPC device produced greater increases
in mean velocity.5 However, there has not been aIPC devices, there is still room for improvement in
their efficacy. The major principle behind the use of IPC complete haemodynamic analysis on the effect of in-
creasing maximum inflation pressure, increasing in-is the prevention of venous stasis, which contributes to
DVT formation in postoperative patients. Therefore, flation duration, and decreasing time to maximal
inflation in pneumatic compression devices. Therefore,optimisation of compression parameters to improve
venous return and prevent stasis should improve ef- we studied the haemodynamic profiles in two IPC
devices in the femoral vein (FV) of healthy volunteersficacy. Earlier studies have shown that increased max-
imum pressure and decreased time to maximum by ultrasonography (US) to determine if a higher
maximum inflation pressure and a more rapid inflation
time of foot, ankle and calf compression would im-
∗ Please address all correspondence to: N. Labropoulos, Department prove venous return as compared to lower pressure,of Surgery, Loyola University Medical Center, 2160 South First
Avenue, Maywood, Illinois 60153-3304, U.S.A. slower speed, calf and thigh compression.
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Material and Methods
Subjects
Thirty limbs in 15 healthy volunteers, nine males and
six females, with a mean age of 28±3.7 and range of
24–40 years, without history of DVT, tobacco use,
peripheral arterial disease or venous insufficiency were
recruited for the study.
Velocity
PVV
(Peak venous velocity in cm/s)
AT (Acceleration time in ms)
Time
Fig. 1. Schematic drawing showing the measurements of peak
venous velocity (cm/s) and acceleration time (ms).IPC devices
limbs of five volunteers to study its efficacy. Statistical
Two external pneumatic compression devices were analysis of the data was performed by the paired
compared. IPC-1 is a sequential compression device t-test and the Wilcoxon signed-rank test when the
that applies pressure extending from the ankle to distribution of the data was non-parametric.
thigh (SCD model 5325, Kendall Healthcare Products,
Co., Mansfield, MA, U.S.A.). IPC-1 applies a pre-
selected peak pressure of 45 mmHg, reaches its Results
peak pressure in approximately 12 s and a non-
compression time of 1 min. IPC-2 applies pressure All 15 volunteers were without evidence of thrombo-
to the foot, ankle and calf progressively (VenAssist, embolic disease or venous insufficiency by duplex
ACI Medical, San Marcos, CA, U.S.A.). IPC-2 applies scanning. Peak venous velocity (PVV) was measured
a pressure of 80 mmHg, has a rapid pressure rise prior to application of the devices. Interestingly, PVV
time to maximal pressure of 0.3 s to 0.36 s, maintains at rest was significantly higher in the right than in
inflation for 5.5 s, and has a total cycling time of the left limb (26 cm/s±7.2 and 22 cm/s±5.7; p<0.01).
1 min. Duplex scanning demonstrated different compression
and decompression haemodynamic profiles in IPC-1
and IPC-2, which were similar in each of the 15 vo-
lunteers (Fig. 2). The mean PVV was significantlyMeasurement of haemodynamic variables
increased with the application of both devices
(p<0.0001). The mean PVV for all 30 limbs was sig-Subjects were placed supine on the examining table
nificantly higher in the IPC-2 than in the IPC-1 deviceand allowed to rest for at least 10 min to reduce the
(55.1 cm/s±17.8 and 37.4 cm/s±6.9; p<0.0001) (Fig.effects of muscular contraction and mimic the venous
3). IPC-2 demonstrated a significantly shorter ac-return profile of bed-rest patients. Measurements
celeration time compared with IPC-1 (370 ms±93.4were determined using ultrasound with a 4–7 MHz
and 560 ms±83.5; p<0.0001). When the foot com-linear array transducer (ATL 3000, Bothel, MA,
pression was used alone, there was no significantU.S.A.) and were taken 1 cm above the sa-
change in either the PVV (p=0.08) or the accelerationphenofemoral junction to include the entire venous
time (p=0.67) in the IPC-2 device.outflow from the lower limb. The probe was held
Overall subjects’ compliance was very good withat that site with minimal pressure to avoid com-
both devices. Three subjects commented that the IPC-pressing the CFV and therefore altering the haemo-
1 device induced increased perspiration in their limbsdynamics. Peak venous velocity (PVV) was measured
in the area of the pneumatic cuffs. The higher com-in each of the 30 limbs prior to use of the compression
pression pressure in the IPC-2 was well tolerated, butcuffs. Each device was then applied to both limbs
two subjects said that this pressure might cause someof each of the 15 volunteers. The order in which
discomfort during sleep.the two devices were tested was random, and care
was taken to ensure proper application of the
compression cuffs. PVV and the acceleration time
(the time taken to reach peak velocity from baseline, Discussion
expressed in milliseconds) were then measured in
each limb during three separate compression cycles Pharmacological therapy and pneumatic compression
devices have both been shown to reduce the formation(Fig. 1). The IPC-2 foot cuff alone was used in 10
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Fig. 3. Peak venous velocity (mean±s.d.) at rest and during the
application of IPC-1 and IPC-2. Both devices increased significantly
the femoral vein velocity compared to baseline (p<0.0001). IPC-2
was more effective in increasing the peak venous velocity than IPC-
1 (p<0.0001).
with discomfort and patient non-compliance. Subjects’
compliance was very good with both devices in this
study. Only three subjects experienced increased per-
spiration with the IPC-1 and two thought that IPC-2
pressure might be too high during sleep. However, it
has to be mentioned that in a clinical setting the
compliance may not be as good.
The use of the Kendall IPC, which compresses from
the ankle to the thigh, has become the most widely
used IPC device in postoperative patients. It offers a
preset pressure of 45 mmHg, has a time to maximal
pressure of 12 s, and releases compression for 60 s.
However, few studies have looked at the optimal
compression parameters for increases in venous re-
turn. We measured comparable resting venous ve-
locities reported by others.3,4 Interestingly, we found
a difference between right and left resting venous
velocity. This difference relates with the anatomical
location of the right common iliac artery which crosses
Fig. 2. Duplex scanning of the common femoral vein demonstrating anterior to, thus compressing, the left common iliacthe effects of intermittent pneumatic compression on femoral vein
vein. This compression of the left common iliac veinvelocity. The peak venous velocity is significantly increased with
application of IPC-1 (b) and IPC-2 (c), compared to baseline (a). may result in increased DVT formation in the left vs.
right iliofemoral vein, known as the May–Thurner
Syndrome.of DVT in postoperative patients. Despite the un-
disputed role of pneumatic compression in DVT pro- We demonstrated increased velocity with an in-
flation pressure of 80 mmHg. Others similarly foundphylaxis, there remains room for improvement in
efficacy. Improper application of IPC devices has been increased velocities with increasing pressures and de-
creasing time to maximal pressure. Ricci et al. studiedshown to reduce the efficacy of IPC devices in the
reduction of DVT formation. Poor patient and nursing the effects of maximal inflation pressure and time to
maximal pressure in IPC foot devices.3 They dem-compliance, as well as improper application of the
compression devices may also be important de- onstrated that increases in maximal pressure (130 and
160 mmHg) and decreases in time to maximal pressureterminants in IPC efficacy.6 We did not look at the
haemodynamic effects of pressures greater than (3.75 and 2 s) resulted in increases in peak velocity
(35.8 cm/s±9.1 and 37.5 cm/s±10.0) and acceleration100 mmHg, as these parameters may be associated
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(101 ms±65 and 104 ms±81) at the CFV. Nicolaides et is unclear,8 although previous studies have dem-
onstrated enhanced fibrinolytic activity with externalal. looked at the effects of increasing maximal pressures
pneumatic compression.9–11 Other authors have shownwith the use of a full-length, six-chambered IPC de-
increased release of tissue plasminogen activatorvice.7 They failed to see a linear relationship between
(tPA)12 and tissue factor pathway inhibitor (tFPI)13 byincreases in maximum pressure and increases in peak
increasing the shear rate. It is conceivable that similaror mean velocity. However, they demonstrated a
effects would be observed in humans, which maygreater % peak velocity increase at 60 mmHg than at
prove beneficial in prevention of DVT by activation35 mmHg. We had similar findings that demonstrate
of the fibrinolytic pathway. Summaria et al. studiedincreased peak velocity at 80 than 45 mmHg in IPC-2
postoperative patients receiving SCD and TED hoseand IPC-1, respectively.
prophylaxis and found the patients without DVT for-In the first 10 volunteers, femoral vein volume flow
mation had significantly higher fibrinolytic activitywas measured. It was shown that the coefficient of
than patients who developed DVT.14variation of this measurement ranged from 14 to 76%.
However, the increase of the flow volume was at least
two times higher than the highest variation in the
flow measurement. Therefore, venous return increases
Conclusionsduring the application of intermittent pneumatic com-
pression. Because of the high variation in the volume
On the basis of our findings, we conclude that in-flow measurement and the lack of any good data
creased maximal inflation pressure, decreased time tosupporting such measurements in peripheral veins, it
maximal pressure and progressive compression of thewas decided to discontinue flow measurements in the
foot, ankle and calf regions results in increased peaklast 10 subjects.
venous velocity and decreased time to peak velocity.Killewich et al. looked at the effects of decreasing
The clinical effects of increased peak venous velocitypulse duration during IPC of the foot.4 They dem-
and decreased time to acceleration, however, have notonstrated that decreased inflation duration (1 and 3 s)
yet been determined. Further studies are needed toresulted in increased maximal venous velocity in the
evaluate the clinical efficacy on DVT formation withpopliteal vein (43.9 cm/s±1.4 and 47.5 cm/s±1.8) in
these compression parameters.supine patients. No difference was seen in supine
patients at the common femoral vein or at either site
with reverse Trendelenburg position. We looked at the
haemodynamic profile of patients while in the supine References
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